These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 8236402)

  • 1. The treatment of kala-azar in the Sudan with sodium stibogluconate: a randomized trial of three dosage regimens.
    Zijlstra EE; Siddig Ali M; el-Hassan AM; Hofland HW; el-Toum I; Satti M; Ghalib HW
    Trans R Soc Trop Med Hyg; 1993; 87(3):307-9. PubMed ID: 8236402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiological, clinical and therapeutic features of Bihar kala-azar (including post kala-azar dermal leishmaniasis).
    Thakur CP
    Trans R Soc Trop Med Hyg; 1984; 78(3):391-8. PubMed ID: 6087515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sodium stibogluconate and paromomycin for treating visceral leishmaniasis under routine conditions in eastern Sudan.
    Atia AM; Mumina A; Tayler-Smith K; Boulle P; Alcoba G; Elhag MS; Alnour M; Shah S; Chappuis F; van Griensven J; Zachariah R
    Trop Med Int Health; 2015 Dec; 20(12):1674-84. PubMed ID: 26427033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post kala-azar dermal leishmaniasis in the Sudan: clinical features, pathology and treatment.
    el Hassan AM; Ghalib HW; Zijlstra EE; Eltoum IA; Satti M; Ali MS; Ali HM
    Trans R Soc Trop Med Hyg; 1992; 86(3):245-8. PubMed ID: 1329273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cumulative cardiac toxicity of sodium stibogluconate and amphotericin B in treatment of kala-azar.
    Maheshwari A; Seth A; Kaur S; Aneja S; Rath B; Basu S; Patel R; Dutta AK
    Pediatr Infect Dis J; 2011 Feb; 30(2):180-1. PubMed ID: 20823781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rationalisation of regimens of treatment of kala-azar with sodium stibogluconate in India: a randomised study.
    Thakur CP; Kumar M; Kumar P; Mishra BN; Pandey AK
    Br Med J (Clin Res Ed); 1988 Jun; 296(6636):1557-61. PubMed ID: 2840172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence that the high incidence of treatment failures in Indian kala-azar is due to the emergence of antimony-resistant strains of Leishmania donovani.
    Lira R; Sundar S; Makharia A; Kenney R; Gam A; Saraiva E; Sacks D
    J Infect Dis; 1999 Aug; 180(2):564-7. PubMed ID: 10395884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical aspects of kala-azar in children from the Sudan: a comparison with the disease in adults.
    Zijlstra EE; Ali MS; el-Hassan AM; el-Toum IA; Satti M; Ghalib HW
    J Trop Pediatr; 1992 Feb; 38(1):17-21. PubMed ID: 1315397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aminosidine plus sodium stibogluconate for the treatment of Indian kala-azar: a randomized dose-finding clinical trial.
    Thakur CP; Bhowmick S; Dolfi L; Olliaro P
    Trans R Soc Trop Med Hyg; 1995; 89(2):219-23. PubMed ID: 7778155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of treatment regimens of kala-azar based on culture & sensitivity of amastigotes to sodium antimony gluconate.
    Thakur CP; Thakur S; Narayan S; Sinha A
    Indian J Med Res; 2008 Jun; 127(6):582-8. PubMed ID: 18765878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amphotericin versus sodium stibogluconate in first-line treatment of Indian kala-azar.
    Mishra M; Biswas UK; Jha AM; Khan AB
    Lancet; 1994 Dec; 344(8937):1599-600. PubMed ID: 7983993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post kala-azar ocular leishmaniasis.
    el Hassan AM; Khalil EA; el Sheikh EA; Zijlstra EE; Osman A; Ibrahim ME
    Trans R Soc Trop Med Hyg; 1998; 92(2):177-9. PubMed ID: 9764325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression profiling of Sudanese visceral leishmaniasis patients pre- and post-treatment with sodium stibogluconate.
    Salih MAM; Fakiola M; Lyons PA; Younis BM; Musa AM; Elhassan AM; Anderson D; Syn G; Ibrahim ME; Blackwell JM; Mohamed HS
    Parasite Immunol; 2017 Jun; 39(6):. PubMed ID: 28370072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomised controlled trial of aminosidine (paromomycin) v sodium stibogluconate for treating visceral leishmaniasis in North Bihar, India.
    Jha TK; Olliaro P; Thakur CP; Kanyok TP; Singhania BL; Singh IJ; Singh NK; Akhoury S; Jha S
    BMJ; 1998 Apr; 316(7139):1200-5. PubMed ID: 9583927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conflict and kala-azar: determinants of adverse outcomes of kala-azar among patients in southern Sudan.
    Collin S; Davidson R; Ritmeijer K; Keus K; Melaku Y; Kipngetich S; Davies C
    Clin Infect Dis; 2004 Mar; 38(5):612-9. PubMed ID: 14986243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seroepidemiological study on kala-azar in Baringo District, Kenya.
    Jahn A; Lelmett JM; Diesfeld HJ
    J Trop Med Hyg; 1986 Apr; 89(2):91-104. PubMed ID: 3021967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnitude of unresponsiveness to sodium stibogluconate in the treatment of visceral leishmaniasis in Bihar.
    Das VN; Ranjan A; Bimal S; Siddique NA; Pandey K; Kumar N; Verma N; Singh VP; Sinha PK; Bhattacharya SK
    Natl Med J India; 2005; 18(3):131-3. PubMed ID: 16130613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sudanese mucosal leishmaniasis: epidemiology, clinical features, diagnosis, immune responses and treatment.
    el-Hassan AM; Meredith SE; Yagi HI; Khalil EA; Ghalib HW; Abbas K; Zijlstra EE; Kroon CC; Schoone GJ; Ismail A
    Trans R Soc Trop Med Hyg; 1995; 89(6):647-52. PubMed ID: 8594683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of generic and proprietary sodium stibogluconate for the treatment of visceral leishmaniasis in Kenya.
    Moore E; O'Flaherty D; Heuvelmans H; Seaman J; Veeken H; de Wit S; Davidson RN
    Bull World Health Organ; 2001; 79(5):388-93. PubMed ID: 11417033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A thirty day course of sodium stibogluconate for treatment of Kala-azar in Nepal.
    Karki P; Koirala S; Parija SC; Hansdak SG; Das ML
    Southeast Asian J Trop Med Public Health; 1998 Mar; 29(1):154-8. PubMed ID: 9740292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.